ID

30876

Description

Single Autologous Stem Cell Transplantation Followed by Maintenance Therapy as Front-line Treatment for Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00892346

Link

https://clinicaltrials.gov/show/NCT00892346

Keywords

Versions (1)
  1. 6/29/18 6/29/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

June 29, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Multiple Myeloma NCT00892346

English

Eligibility Multiple Myeloma NCT00892346

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
man or woman between age 18-65 with newly diagnosed multiple myeloma for whom stem cell transplantation is considered appropriate
Description

Age | Multiple Myeloma | Patient Appropriate Stem cell transplant

Data type

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0026764
UMLS CUI [3,1]
C0030705
UMLS CUI [3,2]
C1548787
UMLS CUI [3,3]
C1504389
measurable serum and/or urinary paraprotein
Description

Serum paraprotein measurement | Urine paraprotein measurement

Data type

boolean

Alias
UMLS CUI [1]
C0585639
UMLS CUI [2]
C0585640
european cooperative oncology group performance status 0-3
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
serum bilirubin < 1.5x the upper limit of normal (uln)
Description

Serum total bilirubin measurement

Data type

boolean

Alias
UMLS CUI [1]
C1278039
serum alanine transaminase (alt)/aspartate transaminase values < 2.5 x uln
Description

Alanine aminotransferase measurement | Aspartate aminotransferase measurement

Data type

boolean

Alias
UMLS CUI [1]
C0201836
UMLS CUI [2]
C0201899
subjects (or their legally acceptable representatives) must signed an informed consent document indicating that they understanding the purpose of and procedures required for the study and are willing to participate in the study
Description

Informed Consent | Informed Consent Patient Representatives

Data type

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2,1]
C0021430
UMLS CUI [2,2]
C0030701
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
woman of child bearing potential
Description

Childbearing Potential

Data type

boolean

Alias
UMLS CUI [1]
C3831118
non-secretory mm
Description

Non-secretory myeloma

Data type

boolean

Alias
UMLS CUI [1]
C0456845
serum creatinine > 400 micromol/l after initial resuscitation
Description

Creatinine measurement, serum | Status post Resuscitation Initial

Data type

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C0035273
UMLS CUI [2,3]
C0205265
patients with previous grade 2-4 peripheral neuropathy
Description

Peripheral Neuropathy CTCAE Grades

Data type

boolean

Alias
UMLS CUI [1,1]
C0031117
UMLS CUI [1,2]
C1516728
uncontrolled diabetes (if receiving antidiabetic agents, subjects must be on a stable dose for at least 3 months before first dose of study drug
Description

Diabetic - poor control | Antidiabetics Dose Stable

Data type

boolean

Alias
UMLS CUI [1]
C0421258
UMLS CUI [2,1]
C0935929
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0205360
uncontrolled or severe cardiovascular disease including myocardial infarction within 6 months of enrollment, uncontrolled angina, clinically significant pericardial disease, or iii-iv heart failure
Description

Cardiovascular Disease Uncontrolled | Cardiovascular Disease Severe | Myocardial Infarction | Angina Pectoris Uncontrolled | Disorder of pericardium | Heart failure NYHA

Data type

boolean

Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0007222
UMLS CUI [2,2]
C0205082
UMLS CUI [3]
C0027051
UMLS CUI [4,1]
C0002962
UMLS CUI [4,2]
C0205318
UMLS CUI [5]
C0265122
UMLS CUI [6,1]
C0018801
UMLS CUI [6,2]
C1275491
Back to the top of the page

Similar models

Eligibility Multiple Myeloma NCT00892346

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age | Multiple Myeloma | Patient Appropriate Stem cell transplant
Item
man or woman between age 18-65 with newly diagnosed multiple myeloma for whom stem cell transplantation is considered appropriate
boolean
C0001779 (UMLS CUI [1])
C0026764 (UMLS CUI [2])
C0030705 (UMLS CUI [3,1])
C1548787 (UMLS CUI [3,2])
C1504389 (UMLS CUI [3,3])
Serum paraprotein measurement | Urine paraprotein measurement
Item
measurable serum and/or urinary paraprotein
boolean
C0585639 (UMLS CUI [1])
C0585640 (UMLS CUI [2])
ECOG performance status
Item
european cooperative oncology group performance status 0-3
boolean
C1520224 (UMLS CUI [1])
Serum total bilirubin measurement
Item
serum bilirubin < 1.5x the upper limit of normal (uln)
boolean
C1278039 (UMLS CUI [1])
Alanine aminotransferase measurement | Aspartate aminotransferase measurement
Item
serum alanine transaminase (alt)/aspartate transaminase values < 2.5 x uln
boolean
C0201836 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
Informed Consent | Informed Consent Patient Representatives
Item
subjects (or their legally acceptable representatives) must signed an informed consent document indicating that they understanding the purpose of and procedures required for the study and are willing to participate in the study
boolean
C0021430 (UMLS CUI [1])
C0021430 (UMLS CUI [2,1])
C0030701 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Childbearing Potential
Item
woman of child bearing potential
boolean
C3831118 (UMLS CUI [1])
Non-secretory myeloma
Item
non-secretory mm
boolean
C0456845 (UMLS CUI [1])
Creatinine measurement, serum | Status post Resuscitation Initial
Item
serum creatinine > 400 micromol/l after initial resuscitation
boolean
C0201976 (UMLS CUI [1])
C0231290 (UMLS CUI [2,1])
C0035273 (UMLS CUI [2,2])
C0205265 (UMLS CUI [2,3])
Peripheral Neuropathy CTCAE Grades
Item
patients with previous grade 2-4 peripheral neuropathy
boolean
C0031117 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
Diabetic - poor control | Antidiabetics Dose Stable
Item
uncontrolled diabetes (if receiving antidiabetic agents, subjects must be on a stable dose for at least 3 months before first dose of study drug
boolean
C0421258 (UMLS CUI [1])
C0935929 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
Cardiovascular Disease Uncontrolled | Cardiovascular Disease Severe | Myocardial Infarction | Angina Pectoris Uncontrolled | Disorder of pericardium | Heart failure NYHA
Item
uncontrolled or severe cardiovascular disease including myocardial infarction within 6 months of enrollment, uncontrolled angina, clinically significant pericardial disease, or iii-iv heart failure
boolean
C0007222 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0007222 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0027051 (UMLS CUI [3])
C0002962 (UMLS CUI [4,1])
C0205318 (UMLS CUI [4,2])
C0265122 (UMLS CUI [5])
C0018801 (UMLS CUI [6,1])
C1275491 (UMLS CUI [6,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial